
Boehringer Ingelheim has said it plans to invest around €17 million in its biopharmaceutical development and manufacturing capabilities at Biberach, …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

